NextGen Sciences

This story has been updated to correct a statement regarding H1 revenues from NextGen's biomarker qualification panels.

Movers & Shakers

Premium

Glenn Barney, Dario Alessi, Philip Cohen, Stephane Bancel, Noubar Afeyan

New Products

Premium

Agilent, Thermo Fisher Scientific, Waters, NextGen Sciences, Protea Biosciences, Origene

New Products

Premium

NanoInk, Integromics, NextGen Sciences, Avantra Biosciences, ProImmune

The figure comes from a report commissioned by proteomics firm Proteome Sciences, which, like a number of other protein biomarker firms including Quanterix, Rules-Based Medicine, and NextGen Sciences, has made AD a significant focus of its R&D and commercialization efforts.

The bump in revenues comes amid a shift in the company's business model during 2010 to focus on "higher value, scalable projects."

With the deal, Myriad will acquire RBM's biomarker discovery platform as well as its pipeline of proprietary protein biomarker-based diagnostics, including two tests that a Myriad official said were "relatively close to commercial launch."

New Products

Premium

Olink Bioscience, NextGen Sciences, Sage-N Research, Origene

Pages

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.